Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent

Newron Pharmaceuticals further expands its intellectual property portfolio for Evenamide with a new EU composition of matter ...
News-Medical.Net on MSN

Two isoforms of a cellular energy sensor play distinct, opposing roles in Alzheimer's disease

A comprehensive mini-review published today after peer review in Brain Medicine by Dr. Tao Ma and colleagues at Wake Forest ...
PharmiWeb

Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent EP4615820 – “Crystalline Forms of Evenamide” is expected to ...

Ad hoc announcement pursuant to Art. 53 LR Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent EP4615820 – “Crystalline Forms of Evenamide” is ...

Newron Pharmaceuticals S.p.A.: Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent

Ad hoc announcement pursuant to Art. 53 LR EP4615820 "Crystalline Forms of Evenamide" is expected to extend asset exclusivity in EU into 2044 Evenamide is currently being investigated in Newron's ...